Why the study?
Is a one-time screening program cost-effective in an asymptomatic population with a high prevalence of carotid stenosis?
Is a one-time screening program cost-effective in an asymptomatic population with a high prevalence of carotid stenosis?
A one-time screening program for asymptomatic carotid stenosis may be cost-effective in high-prevalence populations, but annual screening is detrimental.
No takes yet. Share an insight, caveat, or question.
May support one-time screening in high-prevalence groups; leaves open prospective validation of model assumptions.
Derdeyn et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: